The CO*RE/ASAM Opioid Prescribing: Safe Practice, Changing Lives
Saturday, May 20, 2017
8:00 am - 10:00 am (EST)
Hosted by the Floyd Memorial Foundation
Sponsored by the American Society of Addiction Medicine
KYE's II
500 Missouri Avenue
Jeffersonville, Indiana
Review safe prescribing habits and examine the difference between extended release/long acting medications to help ensure patient safety and effective pain management. Join us at 7:30 am (EST) for free breakfast and networking before the start of the course.
Course Outline
- Assessing Patients for Treatment with ER/LA Opioid Analgesic Therapy
- Initiating Therapy, Modifying Dosing, and Discontinuing Use of ER/LA Opioid Analgesics
- Managing Therapy with ER/LA Opioid Analgesics
- Counseling Patients & Caregivers about Safe Use of ER/LA Opioid Analgesics
- General Drug Information for ER/LA Opioid Analgesics
- Specific Drug Information for ER/LA Opioid Analgesic Products
- Is My Patient Opioid Addicted? -- Diagnosis and Management
Who Should Attend
- All prescribers of ER/LA Opioids
- All health professional affected by the prescription ER/LA Opioids
CME Information
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Addiction Medicine designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Acknowledgement
Presented by the American Society of Addiction Medicine, a member of the Collaborative on REMS Education (CO*RE), 10 interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.
RPC Commercial Support Disclosure Statement
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).
Speaker
Dr. Edwin A. Salsitz, MD, DFASAM
Dr. Edwin A. Salsitz has been an attending physician in the Mount Sinai Beth Israel, Division of Chemical Dependency, since 1983, and is an Assistant Professor of Medicine at the Mount Sinai Icahn School of Medicine. He is the principal investigator of the Methadone Medical Maintenance office-based methadone maintenance) research project. Dr. Salsitz is certified by the American Board of Addiction Medicine (ABAM), as well as by the Board of Internal Medicine and Pulmonary Disease. He has published and lectures frequently on addiction medicine topics.
Dr. Salsitz is a course director for ASAM sponsored buprenorphine trainings, and is a mentor in the PCSS mentoring program, both for buprenorphine and opioids. He has co-chaired the ASAM Review Course, the ASAM Common Threads Course, the ASAM State of the Art course and is a reviewer for the Journal of Addiction Medicine. Dr. Salsitz is the co-chair of the ASAM CME committee and Chair of the New York Society of Addiction Medicine CME and Education committee. He currently is the chair of the ASAM REMS ER/LA Committee.
Dr. Salsitz is a member of the medical advisory panel, for the New York State Office of Alcohol and Substance Abuse Services.
